Related references
Note: Only part of the references are listed.Prophylactic ranitidine treatment in critically ill children - a population pharmacokinetic study
Ahmed F. Hawwa et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Potassium canrenoate treatment in paediatric patients: a population pharmacokinetic study using novel dried blood spot sampling
Maysa Suyagh et al.
JOURNAL OF HYPERTENSION (2013)
Population pharmacokinetics of single-dose intravenous paracetamol in children
B. S. Mohammed et al.
BRITISH JOURNAL OF ANAESTHESIA (2012)
Pharmacokinetics of Single-Dose Intravenous Ketorolac in Infants Aged 2-11 Months
Mindy N. Cohen et al.
ANESTHESIA AND ANALGESIA (2011)
Ketorolac tromethamine: stereo-specific pharmacokinetics and single-dose use in postoperative infants aged 2-6 months
Anne M. Lynn et al.
PEDIATRIC ANESTHESIA (2011)
Human renal function maturation: a quantitative description using weight and postmenstrual age
Malin M. Rhodin et al.
PEDIATRIC NEPHROLOGY (2009)
Chiral Toxicology: It's the Same Thing...Only Different
Silas W. Smith
TOXICOLOGICAL SCIENCES (2009)
How readily does ketorolac penetrate cerebrospinal fluid in children?
Elina Kumpulainen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Pediatric development of glucuronidation: The ontogeny of hepatic UGT1A4
Shogo J. Miyagi et al.
DRUG METABOLISM AND DISPOSITION (2007)
Limited predictability of amikacin clearance in extreme premature neonates at birth
K Allegaert et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children
BJ Anderson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)